News

12. August 2025

MC Sciences is thrilled to be strengthening our leadership team with the addition of Mikael Dolsten to our Board. His unparalleled experience in advancing transformative medicines to patients will be instrumental in accelerating our promising first-in-class and transformative mast cell-targeting therapeutics to clinical development.

MC Sciences continues to be on track as emerging biotech company extensively expanding our leadership and drug development capabilities to advance our promising novel mast therapeutics to clinics.